Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility
By Udai Kammula, Paul G Cantalupo and Lindsey Kelly
Dr Kirkwood on the Evolving Treatment of Resected Melanoma
By John M Kirkwood
Age-Related Changes in Skin May Contribute to Melanoma Metastases
By Valerie Matthews Mehl and Amy Mone
Staying Sun Safe if You Work Outdoors
By Lisa Lombardi
Sarah Ferguson diagnosed with malignant melanoma – here are the latest treatments for this increasingly common ...
By Sarah L Allinson
Molecular patterns of resistance to immune checkpoint blockade in melanoma
By Martin Lauss, Göran Jönsson and Ingrid Hedenfalk
Lifileucel First Cellular Therapy Approved for Cancer
By Carmen Phillips
Mechanisms of melanoma aggressiveness with age
By Corine Bertolotto
Why some types of melanoma resist targeted therapies
By Imma Perfetto
Cell state dependent effects of Bmal1 on melanoma immunity and tumorigenicity
By Peter Karl Sorger, Meenhard Herlyn and Adam J Wolpaw
Delineating the early dissemination mechanisms of acral melanoma by integrating single-cell and spatial ...
By Jianying Gu, Kangjie Shen and Chuanyuan Wei
Bristol medical students tackling skin cancer disparities
By Sarah Turnnidge
Androgen drives melanoma invasiveness and metastatic spread by inducing tumorigenic fucosylation
By Michael G. White, Jennifer Wargo and Bin Fang
FDA approves groundbreaking treatment for advanced melanoma
By Erika Edwards, Marina Kopf and Anne Thompson
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
By Laura A Bolte, Laurence Zitvogel and Sara Valpione
Synaptic activity promotes melanoma formation
By Daniela Senft
Breaking NGF–TrkA immunosuppression in melanoma sensitizes immunotherapy for durable memory T cell protection
By De Huang, Yuin-Han Loh and Hailan Hu
FDA Approves First Cellular Therapy for Metastatic Melanoma
By Sharon Worcester
New cell-based immunotherapy offered for melanoma – Washington University School of Medicine in St. Louis
By Julia Evangelou Strait
Advanced melanoma survival rates improve significantly from 2013 to 2019, Dutch study finds
By Vijay Kumar Malesu
Mi-2β promotes immune evasion in melanoma by activating EZH2 methylation
By Rutao Cui, Xuebin Liao and Colin R. Goding
Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma | Cell Death & Disease
By Federica Rossin, Laura Falasca and Chiara Romualdi
Functional analysis of recurrent CDC20 promoter variants in human melanoma | Communications Biology
By Ryan C Fields
FDA approves new therapy for hard-to-treat metastatic melanoma
By Jen Christensen
Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma
By Ton Schumacher and John B A G Haanen
Androgen receptor is a determinant of melanoma targeted drug resistance
By Markus Kirolos Youssef, Paola Ostano and Sandro Goruppi
Melanoma Overdiagnoses Are Leading to Unnecessary Treatments
By Syeda Khaula Saad
What Is the Rare Melanoma That Killed Bob Marley?
By Greg Glasgow
FDA Approves TIL Therapy for Unresectable or Metastatic Melanoma
By Darlene Dobkowski
Melanoma is overdiagnosed at 'alarming' rates. Here's what to know.
By Meryl Davids Landau
Microenvironmental Snail1-induced immunosuppression promotes melanoma growth | Oncogene
By Berta Sanchez-Laorden, María Ángela Nieto Toledano and Francisco Javier Rodríguez Baena
Calling attention to nail cancer, an overlooked form of melanoma — one woman shares her story
By Jane C Parikh
Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the ...
By Maria Fortunata Lofiego, Andrea Anichini and Davide Bedognetti
MacroH2A restricts inflammatory gene expression in melanoma cancer-associated fibroblasts by coordinating ...
By Helene Salmon, Claudia Capparelli and Andrew E Aplin
Prospective validation of dermoscopy-based open-source artificial intelligence for melanoma diagnosis (PROVE-AI ...
By Emily A Cowen, Zaeem H. Nazir and Allan C. Halpern
Melanoma Vaccine: What's the Latest?
By Beth Dougherty
Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints | Oncogene
By Cristina Uribe-alvarez, Alison M Kurimchak and Suraj Peri
Causes of death among patients with cutaneous melanoma: a US population-based study | Scientific Reports
By Abdelrahman Yousry Afify
Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy
By Berta Sanchez-Laorden, Maddalen Otaegi and Paula Aldaz
Stage 4 Melanoma: Causes, Symptoms & Treatment Options
By Jessica Migala
Lipid droplets are a metabolic vulnerability in melanoma
By Arianna Baggiolini, Lorenz Studer and Shruthy Suresh
Benefits of Moderna and Merck melanoma vaccine plus Keytruda extend to three years
By Michael Erman and Patrick Wingrove